Drug intelligence / Profile preview

safflower xiaoyao tablets

Development stage
Unknown
Lead developer
Peking University Third Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Safflower Xiaoyao Tablets is a Traditional Chinese Medicine (TCM) formulation developed by the Peking University Third Hospital, primarily indicated for the treatment of premenstrual syndrome (PMS) and related gynecological disorders. The formula is an adaptation of the classic Xiaoyao San, enriched with safflower (Carthamus tinctorius) to enhance its blood-activating and stasis-resolving properties. It works by soothing the liver, regulating qi, and nourishing the blood. Clinically, it is used to alleviate symptoms such as breast tenderness, irritability, and menstrual irregularities associated with liver qi stagnation and blood stasis. As a hospital preparation, it is widely used within the Peking University Third Hospital system for managing menstrual cycle-related distress.

Brand names
Honghua Xiaoyao Pian
Other names
Honghua Xiaoyao TabletsSafflower Xiaoyao Pill
02

Targets

P2Y12 (Purinergic P2Y12 receptor)P2RY1 (Purinergic Receptor P2Y1)

Beyond the preview

Go deeper on safflower xiaoyao tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on safflower xiaoyao tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call